PF-05221304

• Description:

  PF-05221304 is an orally bioavailable, liver-targeted inhibitor of acetyl-CoA carboxylase (ACC), an enzyme that catalyzes the first committed step in de novo lipogenesis (DNL) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  502.57

• Molecular Formula:

  C28H30N4O5

• Notes:

  Research use only, not for human use.

• Receptor:

  ——

• CAS Number:

  1370448-25-1